Genesco (GCO)
(Delayed Data from NYSE)
$25.93 USD
+0.32 (1.25%)
Updated Apr 22, 2024 04:00 PM ET
After-Market: $25.96 +0.03 (0.12%) 7:58 PM ET
4-Sell of 5 4
A Value B Growth B Momentum A VGM
Income Statements
Fiscal Year end for Genesco Inc falls in the month of January .
All items in Millions except EPS data.
1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 | |
---|---|---|---|---|---|
Sales | 2,325 | 2,385 | 2,422 | 1,787 | 2,197 |
Cost Of Goods | 1,226 | 1,249 | 1,241 | 982 | 1,134 |
Gross Profit | 1,099 | 1,136 | 1,181 | 804 | 1,063 |
Selling & Adminstrative & Depr. & Amort Expenses | 1,112 | 1,043 | 1,026 | 912 | 980 |
Income After Depreciation & Amortization | -13 | 93 | 156 | -107 | 83 |
Non-Operating Income | -1 | 0 | 0 | 1 | 2 |
Interest Expense | 8 | 3 | 2 | 5 | 3 |
Pretax Income | -22 | 90 | 153 | -112 | 82 |
Income Taxes | 2 | 18 | 38 | -56 | 21 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -24 | 72 | 115 | -56 | 62 |
Extras & Discontinued Operations | 7 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -17 | 72 | 115 | -56 | 61 |
Depreciation Footnote | 1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 64 | 136 | 199 | -61 | 134 |
Depreciation & Amortization (Cash Flow) | 78 | 43 | 43 | 47 | 50 |
Income After Depreciation & Amortization | -13 | 93 | 156 | -107 | 83 |
Earnings Per Share Data | 1/31/24 | 1/31/23 | 1/31/22 | 1/31/21 | 1/31/20 |
---|---|---|---|---|---|
Average Shares | 11.24 | 12.71 | 14.51 | 14.22 | 15.67 |
Diluted EPS Before Non-Recurring Items | 0.56 | 5.59 | 7.62 | -1.18 | 4.58 |
Diluted Net EPS (GAAP) | -1.50 | 5.66 | 7.92 | -3.97 | 3.92 |
Fiscal Year end for Genesco Inc falls in the month of January .
All items in Millions except EPS data.
1/31/24 | 10/31/23 | 7/31/23 | 4/30/23 | 1/31/23 | |
---|---|---|---|---|---|
Sales | 738.95 | 579.32 | 523.03 | 483.33 | 725.02 |
Cost Of Goods | 396.88 | 300.89 | 273.51 | 254.52 | 388.40 |
Gross Profit | 342.07 | 278.43 | 249.52 | 228.81 | 336.62 |
SG&A, R&D, and Dept/Amort Expenses | 304.76 | 267.57 | 288.14 | 251.81 | 286.78 |
Income After SG&A, R&D, and Dept/Amort Expenses | 37.31 | 10.86 | -38.62 | -23.00 | 49.84 |
Non-Operating Income | -0.15 | -0.15 | -0.15 | -0.09 | -0.05 |
Interest Expense | 1.54 | 2.21 | 2.38 | 1.65 | 1.31 |
Pretax Income | 35.63 | 8.50 | -41.16 | -24.74 | 48.48 |
Income Taxes | 15.34 | 1.91 | -9.53 | -5.87 | 9.28 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 20.29 | 6.59 | -31.63 | -18.88 | 39.20 |
Extras & Discontinued Operations | 6.90 | -0.05 | -0.03 | -0.02 | -0.25 |
Net Income (GAAP) | 27.19 | 6.54 | -31.67 | -18.89 | 38.95 |
Earnings Per Share Data | 1/31/24 | 10/31/23 | 7/31/23 | 4/30/23 | 1/31/23 |
---|---|---|---|---|---|
Average Shares | 11.03 | 10.97 | 11.34 | 11.82 | 12.12 |
Diluted EPS Before Non-Recurring Items | 2.59 | 0.57 | -0.85 | -1.59 | 3.06 |
Diluted Net EPS (GAAP) | 2.29 | 0.60 | -2.79 | -1.60 | 3.05 |